CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 320,827 | ||
| 2024-09-17 | Loxam Teri Director | Option exercise 10b5-1 | +6,250 | $22.70 | $142K | 13,425 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −241 | $114.64 | $28K | 13,184 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −1,445 | $115.32 | $167K | 11,739 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −4,308 | $116.62 | $502K | 7,431 |
| 2024-09-17 | Loxam Teri Director | Sale 10b5-1 | −256 | $117.51 | $30K | 7,175 |
| 2024-09-17 | Loxam Teri Director | Option exercise · Stock Option (right to buy) 10b5-1 | −6,250 | 12,500 | ||
| 2024-09-16 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,000 | $2.42 | $24K | 211,958 |
| 2024-09-16 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,784 | $115.06 | $205K | 210,174 |
| 2024-09-16 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −7,994 | $116.14 | $928K | 202,180 |
| 2024-09-16 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −222 | $116.96 | $26K | 200,646 |
| 2024-09-16 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 42,638 | ||
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +10,000 | $2.42 | $24K | 217,503 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −258 | $108.01 | $28K | 217,245 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,072 | $110.08 | $228K | 215,173 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −3,102 | $111.02 | $344K | 212,071 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,263 | $111.85 | $253K | 209,808 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −367 | $112.95 | $41K | 209,441 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −389 | $114.25 | $44K | 209,052 |
| 2024-09-03 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −344 | $115.15 | $40K | 208,708 |
Page 22 of 39 · 764 trades